Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2006);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;9,892;Q1;193;17;77;2900;1727;77;24,19;170,59;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8,345;Q1;210;34;80;6717;1545;77;17,44;197,56;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741776;7,332;Q1;289;154;927;7542;5434;266;18,75;48,97;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;6,223;Q1;58;8;44;1340;508;44;8,25;167,50;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;4,402;Q1;201;92;359;4902;3449;326;10,69;53,28;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;01637258;4,180;Q1;180;123;204;28210;1890;199;9,03;229,35;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2,857;Q1;194;219;787;20283;3942;777;4,85;92,62;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;20681;Current Opinion in Pharmacology;journal;14714892;2,803;Q1;120;99;310;4333;1934;281;7,71;43,77;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X;2,778;Q1;278;106;370;10158;3176;305;10,00;95,83;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
10;26371;Natural Product Reports;journal;02650568, 14604752;2,753;Q1;157;55;135;9245;929;126;7,80;168,09;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
11;18017;Neuropsychopharmacology;journal;0893133X;2,724;Q1;204;299;777;16903;4456;737;6,02;56,53;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
12;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2,697;Q1;127;118;318;5753;1575;297;5,20;48,75;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
13;29311;Current Cancer Drug Targets;journal;15680096;2,656;Q1;85;37;143;6118;923;136;5,99;165,35;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;2,620;Q1;119;25;85;4024;758;84;8,22;160,96;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2,616;Q1;166;166;573;5932;2790;532;5,27;35,73;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;19963;Molecular Pharmacology;journal;15210111, 0026895X;2,548;Q1;186;416;1161;16007;6087;1133;5,14;38,48;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
17;18148;Pain;journal;03043959;2,495;Q1;238;286;1030;10467;5746;906;5,99;36,60;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
18;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2,412;Q1;173;147;434;4916;2722;327;8,64;33,44;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;12611;Drug Resistance Updates;journal;13687646, 15322084;2,412;Q1;100;19;93;2342;540;86;6,23;123,26;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;145164;Human Genomics;journal;14739542, 14797364;2,394;Q1;49;33;66;1350;237;61;3,98;40,91;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2,339;Q1;232;598;2435;17104;10694;2304;4,52;28,60;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;21000196010;Topics in antiviral medicine;journal;21615853;2,279;Q1;37;18;63;65;265;63;5,00;3,61;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
23;12455;Molecular Therapy;journal;15250024, 15250016;2,219;Q1;158;222;739;9192;3816;654;5,95;41,41;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Molecular Biology (Q2)"
24;5100155080;Neurotherapeutics;journal;19337213;1,932;Q1;100;53;109;4821;606;98;6,18;90,96;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;20435;Neuropharmacology;journal;00283908;1,921;Q1;150;223;746;10528;2967;733;4,08;47,21;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
26;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1,919;Q1;240;864;2263;35369;12999;2235;5,77;40,94;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
27;21782;Psychopharmacology;journal;00333158;1,892;Q1;181;326;1168;17331;4675;1110;4,03;53,16;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
28;26380;Drug and Alcohol Dependence;journal;03768716;1,854;Q1;151;212;468;8887;1853;453;3,80;41,92;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
29;23488;Current Medicinal Chemistry;journal;09298673;1,847;Q1;158;221;599;29642;3295;562;5,55;134,13;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
30;20663;Current Drug Metabolism;journal;13892002;1,835;Q1;97;65;123;7593;834;117;7,15;116,82;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
31;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;1,826;Q1;32;0;14;0;54;14;0,00;0,00;Germany;Springer Verlag;1994, 1996-2003;"Cancer Research (Q1); Oncology (Q1); Pharmacology (Q1)"
32;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1,820;Q1;78;55;147;8234;660;136;4,82;149,71;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
33;20682;Current Pharmaceutical Design;journal;13816128;1,801;Q1;140;364;916;42427;4625;805;5,87;116,56;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
34;21790;Antiviral Therapy;journal;13596535;1,790;Q1;78;129;330;4402;1311;312;4,35;34,12;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;23010;Journal of Controlled Release;journal;01683659;1,788;Q1;237;339;1014;11169;4690;1000;4,23;32,95;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
36;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1,777;Q1;93;95;205;3436;797;170;4,60;36,17;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
37;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1,771;Q1;172;367;1394;9014;5148;1169;4,33;24,56;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
38;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1,761;Q1;102;168;283;7991;1124;281;3,53;47,57;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
39;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1,724;Q1;89;52;184;2347;763;177;4,68;45,13;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
40;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1,720;Q1;161;212;566;7354;2415;556;4,13;34,69;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
41;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1,719;Q1;69;13;36;1808;229;36;5,48;139,08;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
42;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1,706;Q1;209;649;1878;24077;8557;1850;4,32;37,10;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
43;23916;Environmental Pollution;journal;02697491, 18736424;1,679;Q1;194;388;895;15137;2818;883;2,95;39,01;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
44;26795;Controlled Clinical Trials;journal;01972456;1,648;Q1;70;0;118;0;376;106;4,73;0,00;Netherlands;Elsevier BV;1980-2004;Pharmacology (Q1)
45;20084;British Journal of Pharmacology;journal;00071188;1,589;Q1;190;387;1361;17594;4923;1303;3,86;45,46;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
46;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1,571;Q1;89;46;89;3653;475;87;5,22;79,41;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
47;12331;Current Topics in Medicinal Chemistry;journal;15680266;1,554;Q1;104;138;373;14056;1677;328;4,73;101,86;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
48;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1,537;Q1;98;28;70;3857;293;63;3,95;137,75;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
49;20624;Clinical Pharmacokinetics;journal;03125963;1,534;Q1;150;76;244;4983;1382;238;5,06;65,57;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
50;20063;Biochemical Pharmacology;journal;00062952;1,533;Q1;181;313;1377;16520;5323;1320;3,95;52,78;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
51;26512;Tetrahedron;journal;00404020;1,524;Q1;209;1251;3534;57561;10006;3492;2,83;46,01;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
52;20664;Current Drug Targets;journal;13894501;1,512;Q1;92;162;226;19221;910;205;4,46;118,65;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
53;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1,511;Q1;81;53;181;1519;475;176;2,56;28,66;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
54;28792;Cancer Biology and Therapy;journal;15384047;1,490;Q1;101;339;810;10059;1503;509;2,55;29,67;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
55;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1,490;Q1;161;256;698;7907;3151;672;4,22;30,89;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
56;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1,464;Q1;82;40;137;3981;553;131;4,04;99,53;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
57;4400151524;Particle and Fibre Toxicology;journal;17438977;1,458;Q1;83;16;14;852;62;13;4,77;53,25;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
58;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1,446;Q1;70;24;49;3594;195;45;4,11;149,75;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
59;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1,404;Q1;75;55;247;2910;1173;229;5,48;52,91;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
60;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1,398;Q1;153;264;807;11889;3197;788;4,12;45,03;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
61;15576;European Neuropsychopharmacology;journal;0924977X;1,382;Q1;100;89;261;4248;927;256;3,81;47,73;Netherlands;Elsevier BV;1990-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
62;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1,377;Q1;114;221;482;9630;1709;468;3,04;43,57;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
63;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1,357;Q1;78;46;165;2029;642;142;4,81;44,11;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
64;21237;Drug Safety;journal;01145916;1,352;Q1;115;93;267;5283;1098;245;4,41;56,81;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
65;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;1,331;Q1;30;0;18;0;60;17;0,86;0,00;United Kingdom;Blackwell Publishing Inc.;1998, 2000-2004;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
66;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1,329;Q1;143;236;848;11188;2672;829;3,11;47,41;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
67;25218;Toxicological Sciences;journal;10960929, 10966080;1,327;Q1;164;336;917;14275;3244;864;3,74;42,49;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
68;19034;Microbial Drug Resistance;journal;10766294;1,319;Q1;62;48;169;1326;380;169;2,00;27,63;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
69;26514;Tetrahedron Letters;journal;00404039;1,314;Q1;159;1957;6258;57130;16129;6179;2,56;29,19;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
70;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1,313;Q1;138;132;384;3633;1284;377;3,68;27,52;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
71;18005;American Journal of Respiratory Medicine;journal;11756365;1,279;Q1;29;0;42;0;159;42;0,00;0,00;United Kingdom;Adis International Ltd.;2002-2003;"Pharmacology (Q1); Pulmonary and Respiratory Medicine (Q1)"
72;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1,268;Q1;78;84;207;7122;604;195;2,92;84,79;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
73;22072;Current Gene Therapy;journal;15665232;1,267;Q1;65;46;139;6424;578;134;4,38;139,65;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
74;21196;Drug Discovery Today;journal;13596446;1,251;Q1;157;165;866;7818;2916;699;4,16;47,38;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
75;20104;CNS Drug Reviews;journal;1080563X, 15273458;1,246;Q1;52;8;72;573;235;70;2,88;71,63;United States;Neva Press, Inc.;1996-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
76;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1,244;Q1;144;193;616;8730;2078;604;3,36;45,23;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
77;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1,242;Q1;87;131;420;5684;1674;415;4,03;43,39;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
78;23155;Current Vascular Pharmacology;journal;15701611;1,222;Q1;54;37;112;4751;396;109;3,93;128,41;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
79;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1,209;Q1;48;0;172;0;577;159;3,68;0,00;United Arab Emirates;Bentham Science Publishers;2002-2005;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
80;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1,207;Q1;116;113;338;4124;850;323;2,18;36,50;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
81;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;1,205;Q1;38;10;17;1137;64;17;3,76;113,70;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Toxicology (Q1); Cancer Research (Q2)"
82;20049;Behavioural Pharmacology;journal;14735849, 09558810;1,197;Q1;76;75;215;3638;525;205;2,44;48,51;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
83;21123;Pharmaceutical Research;journal;07248741, 1573904X;1,197;Q1;191;236;813;9963;2870;804;3,35;42,22;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
84;29712;Clinical Therapeutics;journal;01492918;1,185;Q1;123;180;629;6431;2177;545;3,72;35,73;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
85;23109;Journal of Psychopharmacology;journal;02698811;1,183;Q1;106;128;286;5833;772;241;3,23;45,57;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
86;23053;Journal of Natural Products;journal;01633864, 15206025;1,162;Q1;124;403;1229;9783;3047;1191;2,52;24,28;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
87;29682;Receptors and Channels;journal;10606823;1,143;Q1;41;0;59;0;159;56;2,42;0,00;United Kingdom;Taylor & Francis;1993-2004;"Clinical Biochemistry (Q1); Pharmacology (Q1); Endocrinology (Q2); Cell Biology (Q3)"
88;17595;Journal of Biomolecular Screening;journal;10870571;1,140;Q1;69;103;220;2841;783;215;3,42;27,58;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)"
89;19617;Antiviral Research;journal;01663542;1,139;Q1;108;121;263;5742;910;260;3,10;47,45;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
90;16088;Journal of Nanobiotechnology;journal;14773155;1,124;Q1;57;13;27;451;95;27;3,81;34,69;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
91;20679;Current Opinion in Investigational Drugs;journal;14724472;1,120;Q1;71;120;491;6787;1429;446;3,06;56,56;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
92;22983;Journal of Clinical Pharmacology;journal;00912700;1,119;Q1;106;139;440;4312;1556;431;3,49;31,02;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
93;24763;Addictive Behaviors;journal;03064603;1,118;Q1;114;213;515;6429;1184;511;2,17;30,18;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
94;22319;Toxicon;journal;00410101;1,115;Q1;116;219;722;8543;1764;703;2,58;39,01;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q1)
95;23079;Journal of Pharmaceutical Sciences;journal;00223549;1,088;Q1;159;244;790;7812;2260;761;2,83;32,02;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
96;21351;Expert Opinion on Investigational Drugs;journal;13543784;1,075;Q1;94;141;431;11102;1383;414;3,29;78,74;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1,074;Q1;110;74;116;3475;401;110;3,65;46,96;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
98;22477;Investigational New Drugs;journal;01676997, 15730646;1,068;Q1;80;64;168;2161;539;162;3,16;33,77;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
99;21333;European Journal of Pharmacology;journal;00142999;1,060;Q1;167;735;2185;29716;6019;2151;2,68;40,43;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q1)
100;25109;Inhalation Toxicology;journal;08958378, 10917691;1,057;Q1;77;112;263;4016;643;255;2,58;35,86;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
101;19984;Assay and Drug Development Technologies;journal;1540658X;1,039;Q1;52;58;184;1542;529;174;2,88;26,59;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2)"
102;25219;Toxicology;journal;0300483X;1,034;Q1;143;312;838;12163;2696;816;2,98;38,98;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
103;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1,032;Q1;61;33;111;1266;362;102;2,91;38,36;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
104;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1,030;Q1;82;49;111;2401;241;108;1,72;49,00;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
105;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1,029;Q1;98;157;405;6303;744;404;1,55;40,15;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
106;25240;Toxicology Letters;journal;03784274;1,018;Q1;129;242;755;8643;2324;734;3,06;35,71;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
107;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1,010;Q1;114;466;1321;12639;2892;1307;2,15;27,12;Netherlands;Elsevier BV;1983-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Spectroscopy (Q2)"
108;15581;Current Pharmaceutical Biotechnology;journal;13892010;1,000;Q1;73;60;146;4656;424;129;3,26;77,60;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
109;22454;International Journal of Pharmaceutics;journal;03785173;0,995;Q1;190;515;1286;14516;3496;1264;2,61;28,19;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
110;21169;Pharmacological Research;journal;10436618, 10961186;0,992;Q1;118;131;462;5742;1376;453;3,10;43,83;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
111;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0,990;Q1;133;1274;3232;29946;8673;3185;2,69;23,51;United Kingdom;Elsevier Ltd.;1991-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
112;18071;Neurotoxicity Research;journal;10298428;0,990;Q1;65;49;171;3284;521;168;3,15;67,02;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
113;18073;NeuroToxicology;journal;0161813X;0,978;Q1;102;136;289;6124;802;279;2,94;45,03;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
114;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0,975;Q1;79;131;274;10747;905;258;3,70;82,04;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Drug Discovery (Q2)"
115;21687;American Journal of PharmacoGenomics;journal;11752203;0,965;Q2;36;0;114;0;383;112;3,41;0,00;United Kingdom;Adis International Ltd.;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
116;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0,965;Q1;49;19;95;2279;255;88;2,57;119,95;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Microbiology (medical) (Q2); Molecular Medicine (Q3)"
117;25075;Ecotoxicology;journal;09639292, 15733017;0,963;Q1;81;70;183;2332;307;174;1,38;33,31;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
118;18966;Mutagenesis;journal;02678357, 14643804;0,947;Q1;82;48;210;1994;561;201;2,46;41,54;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q3); Genetics (clinical) (Q3)"
119;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0,945;Q2;90;154;445;4004;954;434;2,13;26,00;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q2)"
120;20473;Life Sciences;journal;00243205;0,940;Q1;150;691;1660;26636;4649;1644;2,56;38,55;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
121;21167;Pharmacogenomics;journal;14622416;0,939;Q2;83;115;283;4762;799;244;3,60;41,41;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
122;21197;Pharmacology Biochemistry and Behavior;journal;00913057;0,929;Q2;126;259;817;13105;1891;813;2,25;50,60;United States;Elsevier Inc.;1973-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Pharmacology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Biological Psychiatry (Q3)"
123;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0,928;Q1;142;809;1834;28718;4890;1812;2,77;35,50;United Kingdom;Elsevier Ltd.;1993-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
124;23015;Journal of Ethnopharmacology;journal;03788741;0,924;Q2;170;379;1056;11722;2405;1038;2,07;30,93;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
125;13250;Expert Opinion on Biological Therapy;journal;14712598;0,910;Q2;75;117;431;10058;1261;421;3,03;85,97;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2)"
126;16948;Chirality;journal;1520636X, 08990042;0,908;Q2;73;118;355;3702;814;340;2,29;31,37;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
127;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0,908;Q2;60;70;271;3935;641;241;2,67;56,21;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
128;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0,900;Q2;79;261;876;8802;1429;866;1,60;33,72;United States;Wiley-Blackwell;1918-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
129;21165;PharmacoEconomics;journal;11707690;0,898;Q2;91;125;338;4602;865;307;2,60;36,82;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Public Health, Environmental and Occupational Health (Q1); Pharmacology (Q2)"
130;21744;Planta Medica;journal;14390221, 00320943;0,896;Q1;103;248;780;5068;1593;761;1,89;20,44;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
131;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0,889;Q2;87;147;370;3832;1004;348;2,89;26,07;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
132;25096;Food and Chemical Toxicology;journal;02786915;0,884;Q2;149;236;564;9629;1566;548;2,74;40,80;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
133;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0,879;Q2;131;208;669;5586;1734;549;3,15;26,86;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
134;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0,872;Q2;89;116;284;4082;664;268;2,48;35,19;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
135;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0,867;Q2;74;148;604;5979;1335;587;2,34;40,40;Netherlands;Elsevier BV;1996-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
136;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0,859;Q2;59;81;241;3723;657;220;3,07;45,96;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
137;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;0,858;Q2;100;225;489;6138;1307;488;2,75;27,28;Germany;Springer Verlag;1978-ongoing;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2); Toxicology (Q2); Cancer Research (Q3)"
138;25093;Environmental Toxicology;journal;15227278, 15204081;0,853;Q2;69;78;208;2771;376;204;1,66;35,53;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
139;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0,849;Q1;62;0;261;0;716;254;2,99;0,00;United Kingdom;Blackwell Publishing Inc.;1991, 1993-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
140;21455;Progress in Medicinal Chemistry;book series;00796468;0,849;Q2;33;8;23;1253;63;20;2,77;156,63;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
141;25789;Bioorganic Chemistry;journal;00452068, 10902120;0,848;Q2;50;31;128;976;224;124;2,09;31,48;United States;Elsevier Inc.;1971-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
142;14805;Steroids;journal;0039128X;0,848;Q2;95;139;357;4388;1101;356;2,99;31,57;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
143;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0,840;Q2;67;54;148;2444;304;145;2,10;45,26;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q2); Physiology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
144;25125;Journal of Analytical Toxicology;journal;01464760;0,828;Q2;69;114;351;2259;555;330;1,47;19,82;United States;Perston Publications, Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
145;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0,822;Q2;80;138;431;5470;854;419;1,85;39,64;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
146;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0,818;Q2;37;20;113;2180;266;104;2,59;109,00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
147;18075;Neurotoxicology and Teratology;journal;08920362;0,815;Q2;89;72;226;3823;548;212;2,36;53,10;Netherlands;Elsevier BV;1987-ongoing;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q4)"
148;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0,811;Q2;88;139;409;5187;1010;406;2,64;37,32;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
149;20783;Expert Review of Vaccines;journal;14760584;0,810;Q2;75;72;267;5454;636;243;2,26;75,75;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
150;20602;Clinical Neuropharmacology;journal;03625664;0,801;Q2;74;62;205;1759;544;184;3,02;28,37;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
151;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0,790;Q2;78;92;200;3406;388;195;1,94;37,02;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
152;20051;BioDrugs;journal;11738804;0,786;Q2;60;36;126;2287;355;123;3,46;63,53;United Kingdom;Adis International Ltd.;1997-ongoing;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
153;21331;European Journal of Pharmaceutical Sciences;journal;09280987;0,781;Q1;119;147;576;5561;1313;570;2,05;37,83;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
154;25898;Journal of Peptide Science;journal;10752617, 10991387;0,775;Q2;60;111;248;3484;468;239;1,78;31,39;United States;John Wiley & Sons Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
155;24028;Reproductive Toxicology;journal;08906238;0,769;Q2;99;156;268;7243;635;247;2,65;46,43;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
156;22432;International Immunopharmacology;journal;15675769;0,768;Q2;98;245;558;8473;1309;551;2,33;34,58;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
157;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0,767;Q2;83;93;440;4784;958;429;2,43;51,44;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
158;17067;Phytomedicine;journal;09447113;0,758;Q1;105;128;326;3518;670;318;1,89;27,48;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
159;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0,757;Q2;55;62;268;1954;454;256;1,85;31,52;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
160;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0,756;Q2;63;55;187;2115;311;160;1,59;38,45;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
161;20027;BMC Pharmacology;journal;14712210;0,755;Q2;38;15;65;495;146;65;2,14;33,00;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
162;24749;Addiction Biology;journal;13556215, 13691600;0,754;Q2;70;32;133;2334;237;120;2,10;72,94;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
163;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0,754;Q2;99;127;374;6224;789;369;2,05;49,01;Netherlands;Elsevier BV;2000-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
164;21229;Drug News and Perspectives;journal;02140934;0,747;Q2;47;72;249;3000;449;248;1,63;41,67;Spain;J.R. Prous;1990-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
165;17464;European Journal of Medicinal Chemistry;journal;02235234;0,744;Q2;135;177;401;4973;1031;397;2,36;28,10;Netherlands;Elsevier BV;1974-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
166;29053;Molecular Diversity;journal;1573501X, 13811991;0,739;Q2;54;55;160;2825;372;153;2,06;51,36;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
167;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0,737;Q2;36;29;91;4161;222;91;2,30;143,48;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
168;21865;Fundamental and Clinical Pharmacology;journal;07673981;0,733;Q2;64;55;235;2329;564;231;2,15;42,35;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0,730;Q2;91;162;826;6027;1499;821;1,76;37,20;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
170;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0,727;Q1;80;80;205;3224;445;184;2,28;40,30;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
171;16319;IEEE Transactions on Nanobioscience;journal;15361241;0,725;Q1;55;29;117;860;326;112;3,14;29,66;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Electrical and Electronic Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Nanoscience and Nanotechnology (Q3)"
172;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0,717;Q2;90;79;236;3359;483;214;2,11;42,52;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
173;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0,713;Q2;36;14;83;689;171;83;1,71;49,21;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
174;24652;Chemico-Biological Interactions;journal;00092797;0,710;Q2;108;139;419;7060;809;412;1,72;50,79;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
175;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0,708;Q2;43;33;116;3776;303;116;2,83;114,42;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
176;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0,705;Q2;77;142;412;7065;647;403;1,44;49,75;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
177;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0,699;Q2;44;35;134;1435;195;119;1,60;41,00;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
178;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0,697;Q2;56;43;82;1498;162;81;1,48;34,84;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
179;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0,697;Q2;99;183;465;5445;1111;423;2,40;29,75;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;25224;Toxicology in Vitro;journal;08872333;0,696;Q2;96;181;329;7235;813;327;2,36;39,97;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
181;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0,695;Q2;95;164;511;7031;924;501;1,72;42,87;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
182;22318;Toxicological Reviews;journal;11762551;0,695;Q2;42;16;75;1748;163;67;1,76;109,25;United Kingdom;Adis International Ltd.;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
183;23942;Biomedical Chromatography;journal;10990801, 02693879;0,694;Q2;58;179;311;4623;516;308;1,62;25,83;United States;John Wiley & Sons Inc.;1986-ongoing;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
184;25214;Toxicologic Pathology;journal;15331601, 01926233;0,694;Q2;96;94;338;4108;619;311;2,03;43,70;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
185;27087;American Journal of Therapeutics;journal;10752765, 15363686;0,691;Q2;55;95;252;2415;490;229;2,25;25,42;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
186;15840;Journal of Antibiotics;journal;00218820;0,690;Q2;73;107;380;1674;442;330;1,32;15,64;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
187;22575;Cardiovascular Toxicology;journal;15307905;0,686;Q2;47;18;97;848;187;95;1,64;47,11;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
188;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0,686;Q1;58;61;161;843;379;161;2,48;13,82;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
189;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0,685;Q2;46;27;103;801;215;102;2,19;29,67;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
190;24578;Mathematical Medicine and Biology;journal;14778599;0,684;Q2;40;19;52;664;89;51;1,36;34,95;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Environmental Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
191;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0,683;Q2;89;57;187;2791;570;186;2,46;48,96;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
192;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0,682;Q2;45;21;73;1607;140;73;1,88;76,52;United States;Neva Press, Inc.;1988-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
193;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0,680;Q2;64;59;126;2167;289;119;2,43;36,73;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
194;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0,675;Q2;62;56;225;1906;455;223;2,16;34,04;United States;Wiley-Blackwell;1986-ongoing;"Medicine (miscellaneous) (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
195;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0,675;Q2;53;32;147;1171;259;144;1,39;36,59;United States;John Wiley & Sons Inc.;1998-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
196;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0,675;Q2;54;63;214;1837;280;204;1,36;29,16;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
197;24604;Archives of Toxicology;journal;14320738, 03405761;0,674;Q2;96;100;284;3148;539;274;1,76;31,48;Germany;Springer Verlag;1972-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
198;25095;Environmental Toxicology and Pharmacology;journal;13826689;0,669;Q2;72;97;296;4021;449;293;1,23;41,45;Netherlands;Elsevier BV;1996-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
199;28620;Biomedicine and Pharmacotherapy;journal;07533322;0,667;Q2;78;102;382;3967;813;367;1,99;38,89;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
200;23412;Journal of AOAC International;journal;10603271;0,656;Q2;79;215;608;5828;912;598;1,51;27,11;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
201;24785;Alcohol;journal;07418329;0,655;Q2;74;76;216;3130;465;208;2,42;41,18;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2); Biochemistry (Q3); Neurology (Q3); Behavioral Neuroscience (Q4)"
202;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0,651;Q1;104;468;1282;13333;2196;1273;1,68;28,49;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
203;21256;Drugs of Today;journal;16993993, 16994019;0,647;Q2;46;79;246;3531;536;243;2,18;44,70;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
204;144771;Clinical Trials;journal;17407753, 17407745;0,645;Q2;55;47;132;1352;146;118;1,24;28,77;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
205;22378;Vascular Pharmacology;journal;15371891;0,644;Q2;86;110;155;5484;282;152;1,95;49,85;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
206;23009;Journal of Clinical Research;journal;13695207;0,640;Q2;11;2;7;85;14;7;2,80;42,50;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;16067;Reading Teacher;journal;00340561;0,640;Q2;44;74;232;1629;107;227;0,36;22,01;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;0,632;Q1;55;101;296;2244;361;189;1,83;22,22;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
209;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0,628;Q2;78;208;698;6884;1205;685;1,77;33,10;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
210;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0,624;Q2;70;203;327;7865;674;326;2,03;38,74;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
211;18077;Fitoterapia;journal;0367326X;0,618;Q2;90;138;438;2136;598;435;1,15;15,48;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
212;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0,615;Q2;16;0;2;0;3;2;3,00;0,00;United Kingdom;Marius Press;1996-2004;Pharmacology (Q2)
213;22410;Inflammation Research;journal;1420908X, 10233830;0,603;Q2;82;124;411;3484;657;404;1,61;28,10;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
214;19443;American Journal of Health-System Pharmacy;journal;10792082;0,599;Q2;87;371;1274;6728;1376;746;1,99;18,13;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
215;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0,597;Q1;69;39;143;1300;337;139;1,80;33,33;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
216;16533;Phytochemical Analysis;journal;09580344, 10991565;0,597;Q2;63;66;196;1254;260;196;1,23;19,00;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
217;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0,595;Q1;61;43;106;1389;216;100;2,32;32,30;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
218;110172;Progress in Drug Research;book series;0071786X;0,594;Q1;38;0;47;0;77;42;0,90;0,00;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
219;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0,591;Q2;18;7;21;254;39;20;1,88;36,29;United Kingdom;BioMed Central;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
220;144790;Marine Drugs;journal;16603397;0,589;Q2;84;18;17;1338;25;16;1,56;74,33;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
221;84948;Expert Opinion on Drug Delivery;journal;17425247;0,588;Q1;88;53;100;4425;182;93;1,96;83,49;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
222;16573;Phytotherapy Research;journal;10991573, 0951418X;0,588;Q2;112;206;678;5568;1151;675;1,47;27,03;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
223;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0,570;Q2;80;124;342;4399;629;329;1,86;35,48;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
224;21207;Drug Discovery Today: Technologies;journal;17406749;0,568;Q2;41;59;118;1964;257;111;2,32;33,29;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q2); Biotechnology (Q3); Molecular Medicine (Q3)"
225;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0,565;Q2;69;230;695;15432;1413;663;2,15;67,10;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
226;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0,564;Q1;107;193;620;7106;1076;612;1,72;36,82;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
227;25864;Heterocycles;journal;03855414;0,559;Q2;61;418;1041;11955;1110;1025;1,09;28,60;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
228;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0,559;Q3;68;49;134;1620;235;130;1,76;33,06;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Physiology (Q3)"
229;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0,558;Q3;84;374;1021;7807;1423;1018;1,36;20,87;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
230;20570;Chemotherapy;journal;00093157, 14219794;0,556;Q3;49;53;210;1160;324;204;1,62;21,89;Switzerland;S. Karger AG;1963-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
231;19900192900;Molecular Informatics;journal;18681751, 18681743;0,554;Q3;60;84;240;3242;610;229;2,44;38,60;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q4)"
232;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0,543;Q3;78;120;336;2962;392;332;1,04;24,68;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
233;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0,540;Q3;43;68;195;1234;206;188;1,11;18,15;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
234;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0,536;Q3;45;117;236;3611;526;222;2,59;30,86;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
235;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0,536;Q2;76;69;200;2731;359;191;1,77;39,58;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
236;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0,534;Q3;62;97;297;2340;431;281;1,50;24,12;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
237;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0,525;Q3;53;61;179;1791;229;173;1,30;29,36;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
238;14990;Current Neuropharmacology;journal;1570159X;0,515;Q3;58;28;55;3460;47;52;0,90;123,57;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
239;14822;Xenobiotica;journal;00498254, 13665928;0,512;Q3;75;64;246;3426;445;242;1,81;53,53;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
240;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0,508;Q3;61;102;229;3310;415;227;1,76;32,45;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
241;130025;Current Drug Delivery;journal;15672018;0,498;Q1;54;46;83;3115;158;82;1,93;67,72;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
242;23050;Journal of Microencapsulation;journal;02652048, 14645246;0,496;Q2;70;73;199;1674;254;198;0,93;22,93;United Kingdom;Taylor & Francis;1984-ongoing;"Colloid and Surface Chemistry (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
243;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0,486;Q3;54;35;151;2041;270;146;1,89;58,31;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Developmental Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
244;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0,480;Q2;35;100;182;1295;162;180;0,74;12,95;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
245;13671;Biologicals;journal;10958320, 10451056;0,478;Q3;51;51;119;1012;127;114;0,90;19,84;United States;Elsevier Inc.;1990-ongoing;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
246;20026;BMC Clinical Pharmacology;journal;14726904;0,476;Q3;35;7;16;204;37;16;2,17;29,14;United Kingdom;BioMed Central;2001-2012;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
247;4000150314;Chemical Biology and Drug Design;journal;17470277;0,470;-;71;102;277;3068;378;266;1,44;30,08;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q3); Molecular Medicine (Q4)"
248;21194;Pharmacology;journal;00317012, 14230313;0,469;Q3;54;67;265;2281;365;263;1,34;34,04;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
249;19374;AAPS PharmSciTech;journal;15221059, 15309932;0,461;Q2;79;98;227;2210;272;213;1,07;22,55;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q2); Ecology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Aquatic Science (Q3); Drug Discovery (Q3); Ecology, Evolution, Behavior and Systematics (Q3)"
250;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0,458;Q2;46;206;680;4679;556;670;0,87;22,71;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
251;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0,456;Q3;21;28;47;3662;76;43;1,77;130,79;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
252;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0,456;Q3;61;104;363;6390;471;350;1,51;61,44;United Kingdom;Taylor & Francis;1991-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
253;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0,455;Q3;54;25;84;852;105;77;1,03;34,08;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q3)
254;20770;Drug Delivery;journal;10717544;0,451;Q2;52;51;131;1463;187;131;1,55;28,69;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
255;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0,448;Q1;79;194;690;5781;896;681;1,25;29,80;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
256;4000148203;Handbook of Experimental Pharmacology;book series;01712004;0,446;Q1;81;117;96;13365;102;92;1,11;114,23;Germany;Springer Verlag;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q3)"
257;29947;Journal of Chemotherapy;journal;1120009X;0,444;Q3;45;139;404;2673;567;370;1,51;19,23;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
258;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0,442;Q3;58;105;383;1364;347;351;0,94;12,99;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
259;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0,436;Q2;50;53;146;1340;131;143;0,93;25,28;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
260;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0,435;Q3;43;43;79;2462;110;76;1,35;57,26;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
261;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0,433;Q3;65;88;234;2306;295;215;1,18;26,20;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
262;27210;In Vivo;journal;0258851X;0,432;Q3;54;95;373;2380;466;371;1,36;25,05;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
263;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0,430;Q3;63;272;1027;4583;693;1020;0,53;16,85;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
264;130047;Current Drug Discovery Technologies;journal;15701638;0,418;Q3;38;23;46;1460;94;45;2,09;63,48;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q3)
265;4000148406;Clinical Toxicology;journal;15563650;0,412;Q3;85;84;326;1868;448;255;1,77;22,24;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
266;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0,411;Q3;42;37;111;1616;219;111;2,11;43,68;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
267;130063;Pharmacological Reports;journal;17341140, 22995684;0,409;Q3;71;113;368;3792;516;365;1,45;33,56;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
268;19956;Archiv der Pharmazie;journal;15214184, 03656233;0,404;Q2;54;80;214;1909;265;212;1,35;23,86;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
269;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;0,403;Q2;106;36;50;1255;80;41;1,95;34,86;Netherlands;Elsevier BV;2005-ongoing;"Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Molecular Medicine (Q4); Nanoscience and Nanotechnology (Q4)"
270;16836;BMC Chemical Biology;journal;14726769;0,400;Q3;19;3;6;90;4;6;0,80;30,00;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q3); Molecular Medicine (Q4)"
271;19958;Archives of Pharmacal Research;journal;02536269;0,394;Q3;75;164;623;4338;631;623;1,00;26,45;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
272;26370;Molecules;journal;14203049;0,392;Q2;116;99;364;2398;346;347;0,85;24,22;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Medicine (Q4)"
273;23489;Chemical Speciation and Bioavailability;journal;09542299;0,388;Q3;25;14;48;516;44;46;0,82;36,86;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
274;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0,379;Q3;38;27;94;858;101;92;1,18;31,78;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
275;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0,379;Q3;8;0;49;0;15;42;0,36;0,00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
276;21262;Drugs under Experimental and Clinical Research;journal;03786501;0,378;Q3;37;0;105;0;150;105;1,44;0,00;Switzerland;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
277;21264;Drugs in R and D;journal;11745886;0,377;Q3;39;31;191;1663;226;190;1,37;53,65;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
278;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0,371;Q3;33;34;64;499;40;53;0,75;14,68;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
279;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0,367;Q2;52;48;228;1026;214;200;1,03;21,38;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
280;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0,364;Q2;54;40;142;1238;169;142;1,17;30,95;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
281;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0,362;Q3;41;121;318;2191;228;314;0,73;18,11;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3); Biochemistry (Q4)"
282;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0,359;Q3;26;82;131;3717;115;123;0,93;45,33;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
283;25144;Journal of Health Science;journal;13475207, 13449702;0,358;Q3;42;126;305;3101;252;305;0,82;24,61;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
284;4000148019;AAPS Journal;journal;15507416;0,356;Q2;96;83;208;5176;309;202;1,71;62,36;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q2)
285;21717;Die Pharmazie;journal;00317144;0,353;Q2;56;214;681;4286;539;675;0,73;20,03;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
286;20580;Journal of Food Biochemistry;journal;01458884;0,351;Q3;40;49;108;1685;82;106;0,79;34,39;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
287;29634;Journal of Negative Results in BioMedicine;journal;14775751;0,346;Q1;19;17;23;629;22;23;1,00;37,00;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
288;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0,345;Q3;44;36;103;974;110;100;0,94;27,06;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
289;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0,343;Q3;58;43;256;1061;193;239;0,28;24,67;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
290;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0,342;Q3;16;0;81;0;122;64;2,60;0,00;Netherlands;Elsevier BV;2003-2004;Drug Discovery (Q3)
291;4400151608;ChemMedChem;journal;18607187, 18607179;0,341;Q2;92;117;457;4906;547;453;1,14;41,93;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3); Molecular Medicine (Q4)"
292;25111;International Journal of Toxicology;journal;10915818, 1092874X;0,339;Q3;51;45;202;2637;205;180;0,88;58,60;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
293;19398;Acta Pharmaceutica;journal;13300075;0,338;Q2;49;40;106;1059;132;104;1,30;26,48;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
294;18800156720;Dissolution Technologies;journal;1521298X;0,337;Q2;28;19;71;222;34;31;1,25;11,68;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
295;13248;Experimental and Toxicologic Pathology;journal;09402993;0,337;Q3;58;60;172;1738;182;171;1,10;28,97;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
296;25106;Human and Experimental Toxicology;journal;09603271;0,337;Q3;71;85;275;3121;328;252;1,22;36,72;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
297;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0,336;Q3;47;70;237;4210;248;236;1,07;60,14;Spain;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
298;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0,336;Q2;29;203;694;2996;361;692;0,51;14,76;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
299;24659;Comments on Toxicology;journal;08865140;0,335;Q3;11;0;12;0;6;10;0,00;0,00;United Kingdom;Taylor & Francis;1995-2003;Toxicology (Q3)
300;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0,335;Q2;38;58;199;1644;134;195;0,71;28,34;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
301;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0,332;Q2;29;0;60;0;78;60;1,10;0,00;Switzerland;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
302;19441;American Journal of Drug Delivery;journal;11759038;0,329;Q3;19;28;42;1319;31;39;0,79;47,11;United Kingdom;Adis International Ltd.;2004-2006;Pharmacology (Q3)
303;21186;Drug Design and Discovery;journal;10559612, 10292322;0,329;Q3;20;0;12;0;14;12;0,00;0,00;United Kingdom;Taylor & Francis;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
304;12000154522;Advances in Antiviral Drug Design;book series;10758593;0,327;Q2;11;0;7;0;8;7;0,00;0,00;United States;JAI Press;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q3)"
305;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0,326;Q3;25;32;79;919;53;67;0,81;28,72;United States;The Haworth Herbal Press;2001-2007;"Pharmacology (Q3); Biochemistry (Q4)"
306;4700152603;Medicinal Chemistry;journal;15734064;0,322;Q3;39;57;63;3062;64;63;1,02;53,72;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
307;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0,320;Q3;55;55;340;1595;264;316;0,77;29,00;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Toxicology (Q3)"
308;15340;Developments in Biologicals;book series;14246074;0,320;Q3;35;106;239;1252;179;239;0,62;11,81;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
309;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0,319;Q3;72;68;51;6929;70;51;1,37;101,90;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Toxicology (Q3)"
310;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0,314;Q2;53;47;91;1419;76;91;0,67;30,19;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
311;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0,313;Q3;30;61;70;1380;56;70;0,56;22,62;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
312;19700180785;Studies in Natural Products Chemistry;book series;15725995;0,313;Q3;33;23;87;2773;36;72;0,20;120,57;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
313;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0,310;Q2;35;43;125;1131;119;122;1,00;26,30;United States;Informa Healthcare;2013-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
314;21082;Pharmaceutical Biology;journal;13880209, 17445116;0,310;Q2;53;107;391;2727;220;385;0,43;25,49;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
315;19383;Fluoride - Quarterly Reports;journal;00154725;0,307;Q3;41;54;124;1134;129;101;1,11;21,00;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4)"
316;21192;Drug Development Research;journal;02724391, 10982299;0,306;Q3;54;97;306;5521;280;298;0,94;56,92;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
317;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0,305;Q3;42;56;159;1721;126;156;0,72;30,73;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
318;17700156431;Handbook of Analytical Separations;book series;15677192;0,304;Q2;11;0;29;0;17;1;0,00;0,00;Netherlands;Elsevier BV;2000-2001, 2003-2004, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Analytical Chemistry (Q3); Pathology and Forensic Medicine (Q3); Environmental Chemistry (Q4)"
319;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0,301;Q3;18;66;199;577;124;193;0,67;8,74;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
320;21100470510;Drug Research;journal;21949379, 21949387;0,291;Q3;56;106;383;2137;296;376;0,64;20,16;Germany;Thieme;1972, 2013-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
321;26767;Altex;journal;1868596X, 18688551;0,286;Q3;45;23;100;411;58;96;0,73;17,87;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
322;23039;Journal of Liposome Research;journal;08982104, 15322394;0,281;Q2;44;33;53;1000;62;49;1,30;30,30;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q2)
323;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0,280;Q3;30;21;62;709;40;62;0,59;33,76;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
324;20634;Journal of Texture Studies;journal;00224901;0,277;Q2;48;45;107;1177;70;105;0,58;26,16;United States;Wiley-Blackwell;1969-ongoing;"Pharmaceutical Science (Q2); Food Science (Q3)"
325;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0,273;Q3;34;34;122;1274;79;117;0,60;37,47;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
326;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0,273;Q2;33;41;124;996;59;95;0,72;24,29;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
327;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0,272;Q2;43;277;797;5558;411;793;0,50;20,06;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
328;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0,271;Q4;30;43;100;1610;64;97;0,68;37,44;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Bioengineering (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
329;20065;BioPharm International;journal;1542166X;0,267;Q2;25;107;405;474;69;347;0,22;4,43;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
330;73430;Pharmaceutical Technology;journal;15432521;0,267;Q2;35;170;549;780;110;335;0,31;4,59;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q3)"
331;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0,265;Q2;50;204;501;3806;165;496;0,31;18,66;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
332;21265;Drugs of the Future;journal;03778282;0,257;Q3;40;110;1328;5444;252;331;0,71;49,49;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
333;21211;Pharmacy Education;journal;14772701, 15602214;0,255;Q2;15;30;97;619;32;96;0,19;20,63;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Education (Q3)"
334;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0,252;Q2;52;145;334;1796;209;321;0,64;12,39;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
335;130007;Drug Design Reviews Online;journal;15672697;0,252;Q2;10;0;48;0;34;48;0,71;0,00;United Arab Emirates;Bentham Science Publishers;2005;"Pharmaceutical Science (Q2); Drug Discovery (Q4); Molecular Medicine (Q4)"
336;35190;Revista Espanola de Quimioterapia;journal;02143429;0,252;Q3;23;51;153;1722;93;136;0,59;33,76;Spain;Sociedad Espaola de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q3); Pharmacology (Q3)"
337;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0,251;Q2;9;45;8;1199;3;8;0,38;26,64;United Kingdom;Blackwell Publishing Inc.;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
338;22456;International Journal of Pharmacy Practice;journal;09617671;0,250;Q2;32;38;99;1008;53;98;0,51;26,53;United Kingdom;Wiley-Blackwell;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Public Health, Environmental and Occupational Health (Q3)"
339;23348;Journal of Environmental Biology;journal;23940379, 02548704;0,245;Q3;40;136;281;3073;109;275;0,36;22,60;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
340;21102;Pharmaceutical Journal;journal;00316873;0,245;Q2;25;1047;7801;1134;245;612;0,37;1,08;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
341;24097;Journal of the Indian Chemical Society;journal;00194522;0,244;Q4;31;279;754;5148;256;738;0,34;18,45;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Electrochemistry (Q3); Drug Discovery (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
342;25253;Blutalkohol;journal;00065250;0,243;Q3;13;20;95;228;27;90;0,23;11,40;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
343;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0,242;Q4;22;72;151;3179;71;135;0,53;44,15;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
344;130089;Toxin Reviews;journal;15569543, 15569551;0,242;Q3;38;27;96;1464;84;83;1,05;54,22;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
345;22375;Indian Drugs;journal;0019462X;0,241;Q3;30;125;408;1836;81;408;0,18;14,69;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
346;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0,240;Q3;32;10;40;351;45;40;0,90;35,10;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
347;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0,240;Q3;14;39;100;4574;44;88;0,50;117,28;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
348;94084;Drug Discovery Today: TARGETS;journal;17418372;0,239;Q4;15;0;126;0;72;104;0,80;0,00;Netherlands;Elsevier BV;2002-2004;Drug Discovery (Q4)
349;4400151410;Human Vaccines;journal;15548600, 15548619;0,235;Q3;49;34;39;987;23;39;0,59;29,03;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Immunology (Q4)"
350;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0,231;Q3;52;47;70;1740;60;69;0,82;37,02;United States;SAGE Publications;1985-ongoing;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
351;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0,230;Q4;27;100;178;1195;70;177;0,40;11,95;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
352;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0,230;Q4;9;29;69;693;32;69;0,46;23,90;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
353;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0,229;Q3;37;33;36;1049;13;31;0,42;31,79;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
354;22411;Inflammopharmacology;journal;09254692, 15685608;0,227;Q3;45;38;136;1467;97;131;0,73;38,61;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
355;130038;Letters in Drug Design and Discovery;journal;15701808;0,227;Q3;28;98;100;3994;66;99;0,67;40,76;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
356;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0,226;Q3;15;47;139;452;25;124;0,19;9,62;United States;SAGE Publications Inc.;2000-ongoing;"Marketing (Q2); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
357;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0,225;Q3;19;40;101;3756;66;91;0,73;93,90;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
358;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0,225;Q3;17;24;43;538;20;36;0,65;22,42;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
359;20578;Journal of Food and Drug Analysis;journal;10219498;0,221;Q3;41;63;184;1505;66;167;0,37;23,89;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
360;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0,221;Q3;9;32;138;212;19;135;0,05;6,63;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
361;73076;Drug Discovery World;journal;14694344;0,220;Q4;10;19;48;158;27;43;0,63;8,32;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
362;79053;Natural Product Sciences;journal;12263907;0,220;Q4;22;47;185;1128;51;183;0,25;24,00;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
363;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0,220;Q3;35;73;134;2826;81;130;0,55;38,71;United Kingdom;Taylor & Francis;1991-ongoing;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
364;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0,219;Q3;24;36;65;837;15;64;0,26;23,25;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
365;19446;American Pharmaceutical Review;journal;10998012;0,217;Q3;20;101;265;1423;102;241;0,43;14,09;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
366;22906;Journal of China Pharmaceutical University;journal;10005048;0,217;Q3;13;90;425;1126;107;425;0,27;12,51;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
367;4700152769;Pharmacopeial Forum;journal;03634655;0,217;Q3;16;45;50;122;21;37;0,65;2,71;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q3)"
368;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0,216;Q3;45;65;221;1359;109;184;0,49;20,91;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
369;25245;Veterinary and Human Toxicology;journal;01456296;0,214;Q4;36;0;219;0;160;203;0,86;0,00;United States;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
370;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0,212;Q3;52;129;321;2111;129;194;0,61;16,36;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
371;21083;Pharmaceutical Care Espana;journal;11396202;0,212;Q3;9;32;107;479;18;91;0,10;14,97;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
372;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0,211;Q3;14;0;12;0;13;12;0,00;0,00;Bulgaria;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
373;13718;Pharmaceutical Engineering;journal;02738139;0,210;Q3;13;61;158;276;20;148;0,14;4,52;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
374;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0,208;Q4;32;28;44;1016;30;42;0,71;36,29;United States;Taylor and Francis;2004-ongoing;"Immunology (Q4); Toxicology (Q4)"
375;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0,205;Q4;25;25;71;946;24;69;0,43;37,84;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
376;22357;IDrugs : the investigational drugs journal;journal;13697056;0,205;Q3;32;159;652;805;301;640;0,48;5,06;United Kingdom;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
377;130072;International Journal of Medicinal Mushrooms;journal;15219437;0,205;Q3;25;38;37;1171;19;37;0,51;30,82;United States;Begell House;2005-ongoing;"Pharmacology (Q3); Applied Microbiology and Biotechnology (Q4); Drug Discovery (Q4)"
378;21127;Pharmaceutical Technology Europe;journal;17537967;0,204;Q3;16;105;269;510;34;156;0,24;4,86;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q3)
379;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0,201;Q3;17;220;693;768;56;677;0,09;3,49;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
380;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0,193;Q3;9;10;19;257;10;19;0,82;25,70;Singapore;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q3)
381;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0,192;Q3;34;31;173;939;72;158;0,45;30,29;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
382;21758;Prescrire International;journal;11677422;0,191;Q3;11;107;432;1185;96;221;0,52;11,07;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
383;19700185200;Journal of Natural Medicines;journal;18610293;0,189;Q3;37;58;161;1084;47;155;0,31;18,69;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
384;21227;Pharmacy in Practice;journal;13581538;0,189;Q3;5;52;199;414;12;165;0,07;7,96;United Kingdom;Medicom Publishing;1995-2009;"Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3)"
385;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0,188;Q3;6;19;79;275;11;66;0,23;14,47;Spain;Alpe Editores;1996-2007;Pharmacology (Q3)
386;20661;Current Drug Discovery;journal;14727463;0,188;Q3;12;0;227;0;60;123;0,50;0,00;United Kingdom;Current Drugs Ltd.;2002-2004;Pharmacology (Q3)
387;21798;Farmaceutski Glasnik;journal;00148202;0,188;Q3;5;16;58;394;6;58;0,13;24,63;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
388;20684;Current Pharmacogenomics;journal;15701603;0,183;Q3;11;26;56;2112;33;56;0,59;81,23;United Arab Emirates;Bentham Science Publishers;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
389;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0,182;Q3;15;37;161;1016;47;161;0,28;27,46;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
390;144613;Journal of Generic Medicines;journal;17411343;0,181;Q3;14;45;101;418;16;85;0,21;9,29;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
391;19381;Acta Farmaceutica Bonaerense;journal;03262383;0,180;Q3;21;100;248;2474;51;248;0,18;24,74;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
392;144963;Drug Discovery Today: Disease Models;journal;17406757;0,177;Q4;23;46;112;1586;32;107;0,30;34,48;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4)"
393;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0,175;Q3;16;30;99;615;18;98;0,19;20,50;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q3)
394;22205;Saudi Pharmaceutical Journal;journal;13190164;0,174;Q3;36;28;72;739;24;70;0,41;26,39;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
395;19405;Acta Poloniae Pharmaceutica;journal;00016837;0,173;Q3;35;102;268;1470;79;267;0,25;14,41;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
396;4700152903;Forensic Toxicology;journal;18608965, 18608973;0,171;Q4;30;17;44;260;13;44;0,23;15,29;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
397;15842;Journal of Applied Research;journal;1537064X;0,170;Q3;18;39;213;880;78;209;0,40;22,56;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
398;22934;Chinese Pharmaceutical Journal;journal;10012494;0,168;Q3;19;435;1206;3664;182;1206;0,13;8,42;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
399;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0,167;Q3;14;25;77;833;14;73;0,16;33,32;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q3)
400;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0,167;Q4;17;139;345;3510;78;321;0,20;25,25;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
401;19399;Acta Pharmaceutica Hungarica;journal;00016659;0,166;Q3;12;24;83;547;12;82;0,24;22,79;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
402;110097;Food and Drug Law Journal;journal;1064590X;0,165;Q4;18;30;111;929;29;107;0,28;30,97;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Pharmacology (Q4)"
403;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0,164;Q4;22;52;124;754;49;124;0,53;14,50;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q4)
404;23171;Korean Journal of Pharmacognosy;journal;02533073;0,163;Q3;14;56;188;1239;30;188;0,18;22,13;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
405;21811;Farmacia Hospitalaria;journal;11306343;0,162;Q4;21;80;224;1436;75;165;0,44;17,95;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
406;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0,161;Q3;15;19;83;352;8;81;0,10;18,53;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q3)
407;25171;Mycotoxin Research;journal;01787888;0,161;Q4;31;43;121;898;28;116;0,12;20,88;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q4); Microbiology (Q4); Toxicology (Q4)"
408;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0,160;Q3;12;87;220;742;20;196;0,08;8,53;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
409;22854;Yakugaku Zasshi;journal;00316903;0,159;Q3;37;139;307;4433;148;305;0,44;31,89;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
410;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0,158;Q4;11;11;65;101;15;65;0,24;9,18;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
411;22908;Chinese Pharmacological Bulletin;journal;10011978;0,157;Q4;15;347;1136;5295;209;1136;0,18;15,26;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q4)
412;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0,157;Q4;33;40;96;1102;26;96;0,27;27,55;United Kingdom;BioMed Central;2000-ongoing;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
413;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0,156;Q3;19;0;42;0;14;33;0,00;0,00;Sweden;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q3); Pharmaceutical Science (Q3)"
414;21795;Farmaceuticky Obzor;journal;00148172;0,154;Q3;7;30;84;717;9;84;0,10;23,90;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
415;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0,154;Q3;26;22;26;952;21;23;0,91;43,27;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
416;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0,154;Q3;14;27;61;553;18;50;0,36;20,48;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
417;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0,154;Q4;23;28;119;637;17;115;0,08;22,75;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
418;21142;Pharmaceutisch Weekblad;journal;00316911;0,152;Q4;9;624;1596;855;44;1197;0,05;1,37;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
419;19427;Advances in Pharmacology;book series;10543589;0,151;Q4;68;31;54;2448;22;50;0,44;78,97;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
420;130150;Advances in Pharmacy;journal;15323862;0,150;Q3;1;0;25;0;3;16;0,19;0,00;United States;Facts and Comparisons;2005;Pharmaceutical Science (Q3)
421;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0,150;Q3;32;61;206;2159;30;192;0,15;35,39;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
422;18384;Medicinal Chemistry Research;journal;10542523;0,146;Q3;38;169;125;833;44;125;0,27;4,93;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
423;16893;Biogenic Amines;journal;15693910, 01688561;0,145;Q4;14;19;85;479;17;82;0,23;25,21;Netherlands;V S P;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
424;145693;Canadian Pharmacists Journal;journal;17151635;0,145;Q3;18;134;413;621;25;261;0,11;4,63;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
425;25197;Revista de Toxicologia;journal;16970748, 02127113;0,144;Q4;9;23;58;570;8;58;0,08;24,78;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
426;86688;Acta Toxicologica;journal;17316383;0,141;Q4;7;17;50;367;7;46;0,13;21,59;Poland;Instytut Medycyny Pracy im. Jerzego Nofera/Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
427;21412;Zeitschrift fr Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0,141;Q4;12;62;156;600;15;124;0,10;9,68;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
428;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0,140;Q4;14;0;18;0;17;15;1,00;0,00;United States;Haworth Integrative Healing Press;2002-2004;Pharmacology (Q4)
429;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0,139;Q4;13;103;92;1780;4;91;0,04;17,28;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
430;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0,138;Q4;26;48;92;1232;23;92;0,26;25,67;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
431;20628;Circular Farmaceutica;journal;00097314;0,137;Q4;2;34;128;250;4;113;0,05;7,35;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
432;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0,136;Q4;6;0;46;0;12;46;0,26;0,00;United Arab Emirates;Bentham Science Publishers;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
433;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0,135;Q3;45;137;52;819;19;50;0,38;5,98;China;Zhejiang University Press;2005-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Veterinary (miscellaneous) (Q4)"
434;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0,134;Q4;11;69;267;1106;36;265;0,14;16,03;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
435;22338;Hospital Pharmacy;journal;00185787;0,134;Q4;21;135;429;1897;61;367;0,17;14,05;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
436;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0,133;Q4;17;9;14;318;2;11;0,18;35,33;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q4); Sports Science (Q4)"
437;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0,133;Q3;7;12;57;207;10;52;0,24;17,25;United States;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
438;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0,132;Q4;9;25;111;930;22;111;0,23;37,20;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
439;22977;Journal de Pharmacie de Belgique;journal;00472166;0,132;Q4;12;19;58;367;13;57;0,25;19,32;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
440;15892;Journal of Drug Evaluation;journal;14791137;0,130;Q4;4;0;46;0;6;19;0,30;0,00;United Kingdom;Parthenon Publishing Group;2003-2004;"Pharmacy (Q3); Pharmacology (Q4)"
441;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0,128;Q4;34;14;73;344;11;71;0,16;24,57;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q4)
442;19461;Annales Pharmaceutiques Francaises;journal;00034509;0,127;Q4;22;48;171;1279;35;165;0,15;26,65;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
443;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0,127;Q4;14;13;78;612;11;70;0,26;47,08;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
444;17716;Quality Assurance Journal;journal;10991786, 10878378;0,127;Q4;7;27;98;222;13;85;0,19;8,22;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
445;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0,126;Q4;37;7;64;387;14;64;0,03;55,29;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
446;19978;Ars Pharmaceutica;journal;00042927, 23409894;0,125;Q4;18;27;70;763;19;68;0,22;28,26;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q4)"
447;21716;Pharmazeutische Zeitung;journal;00317136;0,124;Q4;7;464;1385;859;16;710;0,02;1,85;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
448;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0,124;Q4;26;457;991;4740;171;991;0,15;10,37;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
449;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0,123;Q4;23;44;164;1430;20;163;0,16;32,50;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q4); Physiology (Q4)"
450;21077;Pharmaca;journal;00316857;0,123;Q4;4;11;23;168;2;22;0,11;15,27;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
451;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0,123;Q4;8;37;69;453;5;69;0,07;12,24;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
452;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0,122;Q4;29;0;1;0;0;1;0,00;0,00;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q4)
453;130031;Journal of Toxicologic Pathology;journal;09149198;0,122;Q4;20;30;65;908;10;65;0,14;30,27;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
454;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0,122;Q4;14;36;87;1156;6;83;0,07;32,11;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q4)
455;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0,121;Q4;9;20;64;869;7;64;0,05;43,45;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
456;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0,121;Q4;26;147;479;2750;32;476;0,07;18,71;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
457;20572;PZ Prisma;journal;09455566;0,121;Q4;5;34;97;669;5;84;0,07;19,68;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
458;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0,120;Q4;8;31;94;811;4;91;0,06;26,16;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
459;22514;Japanese Journal of Chemotherapy;journal;13407007;0,118;Q4;12;36;243;685;16;240;0,07;19,03;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
460;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0,117;Q4;2;2;3;73;2;3;0,00;36,50;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
461;144879;Toxicology International;journal;09716580;0,116;Q4;21;20;20;442;3;20;0,15;22,10;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
462;21867;Geneesmiddelenbulletin;journal;03044629;0,115;Q4;6;69;197;225;7;33;0,23;3,26;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
463;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0,114;Q4;18;13;59;173;3;57;0,00;13,31;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
464;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0,114;Q4;6;0;19;0;2;19;0,00;0,00;United States;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q4); Pharmacology (Q4)"
465;19700175108;Drug Delivery System;journal;09135006;0,112;Q4;7;30;118;621;9;118;0,09;20,70;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
466;23107;Journal of Pharmacy Technology;journal;87551225;0,111;Q4;9;37;141;874;11;104;0,09;23,62;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
467;72755;Phytomedica;journal;09723293;0,111;Q4;4;16;54;213;2;54;0,00;13,31;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
468;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0,111;Q4;14;0;2;0;0;2;0,00;0,00;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
469;22887;Chinese Journal of Antibiotics;journal;10018689;0,110;Q4;10;189;603;2130;23;594;0,04;11,27;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
470;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0,110;Q4;13;100;331;1954;23;331;0,05;19,54;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
471;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0,110;Q4;3;85;301;191;3;253;0,01;2,25;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
472;21800;Farmacevtski Vestnik;journal;00148229;0,110;Q4;4;28;201;744;1;200;0,00;26,57;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
473;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0,110;Q4;18;12;18;340;3;17;0,18;28,33;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
474;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0,109;Q4;15;0;34;0;5;32;0,19;0,00;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
475;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0,108;Q4;18;15;57;0;8;57;0,16;0,00;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
476;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0,108;Q4;35;62;53;434;5;53;0,09;7,00;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q4)
477;50087;EBR - European Biopharmaceutical Review;journal;13690663;0,107;Q4;5;76;198;344;5;175;0,03;4,53;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
478;21329;European Journal of Herbal Medicine;journal;13524755;0,107;Q4;2;0;8;0;0;3;0,00;0,00;United Kingdom;National Institute of Medical Herbalists;2001-2004;Pharmacology (Q4)
479;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0,107;Q4;13;65;233;1116;15;228;0,08;17,17;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
480;22979;Journal of Applied Therapeutic Research;journal;10292659;0,107;Q4;7;5;47;96;8;47;0,24;19,20;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
481;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0,107;Q4;15;42;95;1075;9;71;0,09;25,60;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
482;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0,106;Q4;9;6;49;63;5;36;0,16;10,50;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
483;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0,106;Q4;7;0;14;0;3;14;0,00;0,00;United States;PJD Publications Ltd.;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
484;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0,105;Q4;5;0;30;0;5;29;0,17;0,00;France;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
485;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0,105;Q4;4;17;89;725;3;89;0,04;42,65;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
486;21823;Farmatsija;journal;04280296;0,105;Q4;5;19;75;297;3;75;0,05;15,63;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
487;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0,105;Q4;7;72;157;646;4;128;0,03;8,97;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
488;69108;Chemotherapie Journal, Supplement;journal;09446486;0,104;Q4;6;0;6;0;0;5;0,00;0,00;Germany;Wissenschaftliche Verlagsgesellschaft;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
489;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0,104;Q4;7;0;14;0;1;14;0,00;0,00;Turkey;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
490;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0,104;Q4;41;41;8;21;0;6;0,00;0,51;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
491;58808;Pharmaceutical Care and Research;journal;16712838;0,104;Q4;7;100;219;820;3;216;0,01;8,20;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
492;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0,103;Q4;3;15;40;200;1;37;0,04;13,33;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
493;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0,103;Q4;7;0;31;0;1;28;0,08;0,00;United Kingdom;Elsevier Science;1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
494;4000151703;Core Evidence;journal;15551741, 1555175X;0,102;Q4;19;8;12;596;0;11;0,00;74,50;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
495;21238;Drug Topics;journal;00126616;0,102;Q4;7;451;1574;43;17;1389;0,01;0,10;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
496;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0,102;Q4;0;15;28;179;0;10;0,00;11,93;United States;Duke University Press;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
497;18098;Japanese Journal of Psychopharmacology;journal;13402544;0,102;Q4;11;1;9;0;1;9;0,13;0,00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
498;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0,102;Q4;7;0;11;0;0;11;0,00;0,00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
499;86349;Oral Therapeutics and Pharmacology;journal;02881012;0,102;Q4;5;10;50;225;1;50;0,00;22,50;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
500;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0,102;Q4;5;43;123;199;8;97;0,07;4,63;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
501;20543;Pharmacometrics;journal;03008533;0,102;Q4;6;0;65;0;7;57;0,09;0,00;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
502;25196;Revista Brasileira de Toxicologia;journal;14152983;0,102;Q4;6;12;38;464;2;35;0,05;38,67;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
503;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0,102;Q4;11;24;9;316;0;9;0,00;13,17;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
504;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0,102;Q4;8;31;105;725;3;77;0,05;23,39;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
505;5800207507;Side Effects of Drugs Annual;book series;03786080;0,102;Q4;5;0;153;0;4;104;0,06;0,00;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
506;145000;Signal;journal;14719967;0,102;Q4;1;7;22;192;0;10;0,00;27,43;United Kingdom;Adis International Ltd.;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
507;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0,101;Q4;2;36;37;107;0;32;0,00;2,97;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
508;19430;Adverse Drug Reaction Bulletin;journal;00446394;0,101;Q4;7;4;19;152;0;18;0,00;38,00;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
509;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0,101;Q4;6;51;114;73;4;114;0,04;1,43;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
510;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0,101;Q4;7;2;23;23;0;23;0,00;11,50;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
511;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0,101;Q4;22;23;41;0;0;41;0,00;0,00;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
512;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0,101;Q4;5;0;25;0;0;25;0,00;0,00;Italy;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
513;21932;Hindustan Antibiotics Bulletin;journal;00181935;0,101;Q4;8;0;17;0;0;17;0,00;0,00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
514;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;0,101;Q4;2;0;17;0;0;16;0,00;0,00;Netherlands;Elsevier BV;2004;"Immunology (Q4); Toxicology (Q4)"
515;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0,101;Q4;8;17;18;224;0;14;0,00;13,18;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
516;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0,101;Q4;5;269;243;2199;3;243;0,01;8,17;China;Jilin University;2005-ongoing;Pharmacology (Q4)
517;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0,101;Q4;5;0;25;0;0;25;0,00;0,00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
518;130170;Phytotherapie;journal;17652847, 16248597;0,101;Q4;12;43;57;660;1;32;0,03;15,35;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
519;89630;Psychopharmakotherapie, Supplement;journal;09465146;0,101;Q4;2;0;37;0;1;30;0,03;0,00;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
520;19408;Actualites Pharmaceutiques;journal;05153700;0,100;Q4;5;132;495;123;1;310;0,00;0,93;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
521;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0,100;Q4;9;32;81;383;0;80;0,00;11,97;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
522;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0,100;Q4;1;15;79;273;0;70;0,00;18,20;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
523;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0,100;Q4;25;108;272;1190;2;212;0,01;11,02;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
524;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0,100;Q4;8;10;39;790;1;37;0,03;79,00;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
525;80593;Journal of Medicinal Plants;journal;16840240;0,100;Q4;16;44;81;942;1;81;0,01;21,41;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
526;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0,100;Q4;9;0;61;0;0;60;0,00;0,00;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
527;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0,100;Q4;12;24;125;342;2;119;0,00;14,25;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
528;19600162009;Advances in Molecular Toxicology;book series;18720854;;-;10;6;0;761;0;0;0,00;126,83;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
529;19700180757;Advances in Phytomedicine;book series;1572557X;;-;12;43;0;3377;0;0;0,00;78,53;Netherlands;Elsevier BV;2002, 2006;"Drug Discovery; Plant Science"
530;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;;-;36;43;0;1031;0;0;0,00;23,98;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine; Drug Discovery; Medicine (miscellaneous)"
531;6400153120;Chinese Medicine;journal;17498546;;-;34;4;0;235;0;0;0,00;58,75;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine; Pharmacology"
532;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;;-;13;223;0;2001;0;0;0,00;8,97;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine; Drug Discovery; Pharmaceutical Science; Pharmacology (medical)"
533;5800173383;Current Clinical Pharmacology;journal;15748847;;-;33;27;0;2723;0;0;0,00;100,85;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
534;4700152609;Current Computer-Aided Drug Design;journal;15734099;;-;24;20;0;1894;0;0;0,00;94,70;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery; Medicine (miscellaneous); Molecular Medicine"
535;5800173386;Current Drug Safety;journal;15748863;;-;31;33;0;2335;0;0;0,00;70,76;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology; Pharmacology (medical); Toxicology"
536;4700152607;Current Enzyme Inhibition;journal;15734080;;-;15;29;0;4245;0;0;0,00;146,38;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry; Drug Discovery; Molecular Medicine"
537;4700152612;Current Nanoscience;journal;15734137;;-;37;35;0;2729;0;0;0,00;77,97;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Bioengineering; Biomedical Engineering; Biotechnology; Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
538;4700152426;Current Pharmaceutical Analysis;journal;15734129;;-;22;32;0;3266;0;0;0,00;102,06;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry; Biophysics; Molecular Medicine; Pharmaceutical Science"
539;9100153105;Current Topics in Pharmacology;journal;09724559;;-;4;18;0;1285;0;0;0,00;71,39;India;Research Trends;2006-ongoing;"Pharmacology; Pharmacology (medical)"
540;4700152278;Drugs in Context;journal;17404398, 17451981;;-;12;44;0;1113;0;0;0,00;25,30;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine; Pharmacology"
541;5100154302;European Biotechnology Science and Industry News;journal;16188276;;-;2;70;0;15;0;0;0,00;0,21;Germany;Biocom AG;2006-2013;"Biotechnology; Drug Discovery"
542;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;;-;50;65;0;4028;0;0;0,00;61,97;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery
543;5200152843;Farmaceutico Hospitales;journal;02144697;;-;3;8;0;80;0;0;0,00;10,00;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
544;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;;-;8;18;0;1416;0;0;0,00;78,67;United Arab Emirates;Bentham Science Publishers;2006-2009;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
545;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;;-;6;27;0;4364;0;0;0,00;161,63;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery; Molecular Medicine; Organic Chemistry"
546;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;00002006;;-;8;124;0;2000;0;0;0,00;16,13;United States;;2006;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
547;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;;-;42;25;0;2016;0;0;0,00;80,64;United Arab Emirates;Bentham Science Publishers;2006-2015;"Immunology; Immunology and Allergy; Medicine (miscellaneous); Pharmacology"
548;7700153108;International journal of nanomedicine;journal;11782013, 11769114;;-;100;58;0;2691;0;0;0,00;46,40;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering; Biomaterials; Biophysics; Drug Discovery; Medicine (miscellaneous); Nanoscience and Nanotechnology; Organic Chemistry"
549;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;;-;5;26;0;1066;0;0;0,00;41,00;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical); Pharmacology"
550;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;;-;9;119;0;879;0;0;0,00;7,39;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Medicine (miscellaneous); Pharmaceutical Science; Pharmacology (medical); Pharmacology (nursing); Pharmacy"
551;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;;-;29;113;0;2983;0;0;0,00;26,40;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology
552;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;;-;18;31;0;1139;0;0;0,00;36,74;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology
553;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;;-;64;40;0;3423;0;0;0,00;85,58;Germany;Springer Verlag;2006-ongoing;"Immunology; Immunology and Allergy; Neuroscience (miscellaneous); Pharmacology"
554;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;;-;33;27;0;945;0;0;0,00;35,00;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health; Safety Research; Toxicology"
555;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;;-;25;10;0;195;0;0;0,00;19,50;United States;Springer USA;2006-ongoing;"Drug Discovery; Pharmaceutical Science"
556;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;;-;22;60;0;1258;0;0;0,00;20,97;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology; Infectious Diseases; Parasitology; Toxicology"
557;13637;Manufacturing Chemist;journal;02624230;;-;6;10;0;8;0;0;0,00;0,80;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science
558;4200151509;Molecular Diagnosis and Therapy;journal;11771062;;-;34;43;0;2421;0;0;0,00;56,30;United Kingdom;Adis International Ltd.;2006-ongoing;"Genetics; Medicine (miscellaneous); Molecular Medicine; Pharmacology"
559;4700152457;Nano Today;journal;17480132;;-;119;25;0;984;0;0;0,00;39,36;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering; Biomedical Engineering; Biotechnology; Materials Science (miscellaneous); Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
560;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;;-;12;51;0;834;0;0;0,00;16,35;Germany;Springer Verlag;2006-2008;"Biotechnology; Chemistry (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
561;17700155034;Natural product communications;journal;15559475, 1934578X;;-;35;164;0;5621;0;0;0,00;34,27;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine; Drug Discovery; Medicine (miscellaneous); Pharmacology; Plant Science"
562;4500151530;Personalized Medicine;journal;17410541;;-;24;42;0;1935;0;0;0,00;46,07;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous); Molecular Medicine; Pharmacology"
563;5000158120;Pharmacy News;journal;1448207X;;-;1;59;0;0;0;0;0,00;0,00;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science; Pharmacology (nursing)"
564;4700152701;Pharmacy Practice;journal;1885642X, 18863655;;-;19;25;0;602;0;0;0,00;24,08;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmaceutical Science; Pharmacy"
565;5200152604;Pharma Times;journal;00316849;;-;10;25;0;265;0;0;0,00;10,60;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
566;4700152848;PPAR Research;journal;16874757, 16874765;;-;40;12;0;553;0;0;0,00;46,08;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery; Pharmacology (medical)"
567;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;;-;36;27;0;3398;0;0;0,00;125,85;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cancer Research; Drug Discovery; Medicine (miscellaneous); Oncology; Pharmacology (medical)"
568;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;;-;27;30;0;2647;0;0;0,00;88,23;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery; Infectious Diseases; Medicine (miscellaneous); Pharmacology (medical)"
569;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;;-;25;26;0;2568;0;0;0,00;98,77;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine; Drug Discovery; Pharmacology (medical)"
570;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;;-;29;25;0;3055;0;0;0,00;122,20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery; Pharmacology (medical); Psychiatry and Mental Health"
571;5800173387;Reviews on Recent Clinical Trials;journal;15748871;;-;30;30;0;2024;0;0;0,00;67,47;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous); Pharmacology"
572;4100151616;Supportive Cancer Therapy;journal;15432912;;-;13;38;0;1150;0;0;0,00;30,26;United States;Cancer Information Group;2006-2007;"Cancer Research; Oncology; Pharmacology"
573;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;;-;43;47;0;2919;0;0;0,00;62,11;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety; Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Safety Research"
574;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;;-;11;15;0;320;0;0;0,00;21,33;Turkey;Turkish Pharmacists Association;2006-ongoing;"Molecular Medicine; Pharmaceutical Science"
